Candace Graff

1.4k total citations · 1 hit paper
15 papers, 983 citations indexed

About

Candace Graff is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Candace Graff has authored 15 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pediatrics, Perinatology and Child Health and 4 papers in Immunology. Recurrent topics in Candace Graff's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Advanced Drug Delivery Systems (3 papers). Candace Graff is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Advanced Drug Delivery Systems (3 papers). Candace Graff collaborates with scholars based in United States and Switzerland. Candace Graff's co-authors include Gary M. Pollack, Claude Dagenais, Robert J. Padley, Jonathan S. George, Matthew Rosebraugh, Heidi S. Camp, J W Voss, Andrew J. Long, Julie Parmentier and Annette Schwartz and has published in prestigious journals such as The Journal of Immunology, Annals of the Rheumatic Diseases and Biochemical Pharmacology.

In The Last Decade

Candace Graff

15 papers receiving 951 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

2018 276 citations Julie Parmentier, J W Voss et al. BMC Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Candace Graff United States	10	343	223	201	189	135	15	983
Sara Peleg United States	27	310 0.9×	61 0.3×	592 2.9×	60 0.3×	23 0.2×	72	2.1k
Lothar Färber Germany	11	377 1.1×	29 0.1×	251 1.2×	141 0.7×	28 0.2×	16	1.1k
Pamela L. Golden United States	14	319 0.9×	46 0.2×	269 1.3×	204 1.1×	24 0.2×	28	1.2k
Gérard F. Murphy Canada	18	252 0.7×	15 0.1×	209 1.0×	227 1.2×	45 0.3×	38	1.1k
J. Nilsson Sweden	14	157 0.5×	24 0.1×	251 1.2×	63 0.3×	67 0.5×	22	806
Yoshio Takasato Japan	18	315 0.9×	18 0.1×	203 1.0×	125 0.7×	116 0.9×	80	1.4k
Ken Iseki Japan	18	70 0.2×	35 0.2×	536 2.7×	31 0.2×	41 0.3×	82	1.2k
Devorah Gurantz United States	21	556 1.6×	28 0.1×	547 2.7×	157 0.8×	19 0.1×	24	1.6k
Shinobu Mori Japan	13	335 1.0×	14 0.1×	190 0.9×	169 0.9×	21 0.2×	31	787
Yanling Yang China	19	134 0.4×	10 0.0×	857 4.3×	136 0.7×	124 0.9×	138	1.5k

Countries citing papers authored by Candace Graff

Since Specialization

Citations

This map shows the geographic impact of Candace Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace Graff more than expected).

Fields of papers citing papers by Candace Graff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candace Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace Graff. The network helps show where Candace Graff may publish in the future.

Co-authorship network of co-authors of Candace Graff

This figure shows the co-authorship network connecting the top 25 collaborators of Candace Graff. A scholar is included among the top collaborators of Candace Graff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace Graff. Candace Graff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Parmentier, Julie, J W Voss, Candace Graff, et al.. (2018). In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatology. 2(1). 23–23. 276 indexed citations breakdown →

Mozaffari, Mahmood S., Luc Biedermann, Céline Mamie, et al.. (2018). BCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice. Clinical & Experimental Immunology. 193(3). 346–360. 9 indexed citations

Grebe, Kristie M., Stuart J. Perper, Annette Schwartz, et al.. (2015). Venetoclax (ABT-199), a potent and selective BCL-2 inhibitor, is efficacious in NZB/WF1 mouse model of lupus nephritis and reduces human lymphocyte lifespan in vitro (BA4P.127). The Journal of Immunology. 194(1_Supplement). 47.7–47.7. 2 indexed citations

Lutz, Christian, Mahmood S. Mozaffari, Vinko Toševski, et al.. (2015). Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression. Clinical & Experimental Immunology. 181(2). 343–356. 13 indexed citations

Perper, Stuart J., Andrea Wershof Schwartz, Douglas J. Hartman, et al.. (2015). THU0382 Venetoclax (ABT-199), A Potent and Selective BCL-2 Inhibitor, Prevents Nephritis in Lupus Prone NZB/W F1 Mice by Depleting Selective Lymphocyte Populations While Sparing Platelets. Annals of the Rheumatic Diseases. 74. 334–334. 3 indexed citations

Scott, Michael R. Van, Elisabeth Mertsching, Ella Negrou, et al.. (2008). Systemic administration of an Fcγ–Fcε-fusion protein in house dust mite sensitive nonhuman primates. Clinical Immunology. 128(3). 340–348. 14 indexed citations

Graff, Candace & Gary M. Pollack. (2005). Functional Evidence for P-glycoprotein at the Nose-Brain Barrier. Pharmaceutical Research. 22(1). 86–93. 67 indexed citations

Graff, Candace, Rong Zhao, & Gary M. Pollack. (2005). Pharmacokinetics of Substrate Uptake and Distribution in Murine Brain After Nasal Instillation. Pharmaceutical Research. 22(2). 235–244. 28 indexed citations

Graff, Candace & Gary M. Pollack. (2005). Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery. Journal of Pharmaceutical Sciences. 94(6). 1187–1195. 203 indexed citations

10.

Huhalov, Alexandra, Candace Graff, Berend Tolner, et al.. (2004). HSAbodies: A new class of engineered antibody-based molecules for targeting cancer. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

11.

Graff, Candace & Gary M. Pollack. (2004). (Section B: Integrated Function of Drug Transporters In Vivo) Drug Transport at the Blood-Brain Barrier and the Choroid Plexus. Current Drug Metabolism. 5(1). 95–108. 103 indexed citations

12.

Kalvass, J. Cory, Candace Graff, & Gary M. Pollack. (2004). Use of Loperamide as a Phenotypic Probe of mdr1a Status in CF-1 Mice. Pharmaceutical Research. 21(10). 1867–1870. 18 indexed citations

13.

Graff, Candace & Gary M. Pollack. (2003). P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation. Pharmaceutical Research. 20(8). 1225–1230. 60 indexed citations

14.

Dagenais, Claude, Candace Graff, & Gary M. Pollack. (2003). Variable modulation of opioid brain uptake by P-glycoprotein in mice. Biochemical Pharmacology. 67(2). 269–276. 185 indexed citations

15.

Graff, Candace, et al.. (1971). [Behavior of vegetative and biochemical parameters in essential hypertension during psychologic stress].. PubMed. 26(1). 6–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact